Kieu Lam
April 14, 2025
Kieu Lam has served as Vice President, Research of Genevant Sciences Corporation since April 2025. Previously, she was Genevant’s Senior Director, Technology Development since its inception in 2018. Prior to joining Genevant, Kieu served in formulation development, preclinical research, and process development roles at Arbutus Biopharma, Tekmira Pharmaceuticals, Protiva Biotherapeutics, and Inex Pharmaceuticals. She brings over 20 years of experience in the field of nucleic acid delivery and is an inventor of foundational lipid nanoparticle technology. She holds a BSc in Molecular Microbiology and Biotechnology from the University of British Columbia.